AXIOFILL Trademark

Trademark Overview


On Thursday, April 14, 2022, a trademark application was filed for AXIOFILL with the United States Patent and Trademark Office. The USPTO has given the AXIOFILL trademark a serial number of 97362874. The federal status of this trademark filing is REGISTERED as of Tuesday, January 17, 2023. This trademark is owned by MiMedx Group, Inc.. The AXIOFILL trademark is filed in the Pharmaceutical Products category with the following description:

Human allograft tissue
axiofill

General Information


Serial Number97362874
Word MarkAXIOFILL
Filing DateThursday, April 14, 2022
Status700 - REGISTERED
Status DateTuesday, January 17, 2023
Registration Number6959111
Registration DateTuesday, January 17, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements


Goods and ServicesHuman allograft tissue

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 19, 2022
Primary Code005
First Use Anywhere DateMonday, September 19, 2022
First Use In Commerce DateMonday, September 19, 2022

Trademark Owner History


Party NameMiMedx Group, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMarietta, GA 30062

Party NameMiMedx Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMarietta, GA 30062

Party NameMiMedx Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMarietta, GA 30062

Trademark Events


Event DateEvent Description
Tuesday, January 17, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 17, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, December 13, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 12, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 10, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 2, 2022USE AMENDMENT FILED
Thursday, November 10, 2022SOU EXTENSION 1 GRANTED
Wednesday, November 2, 2022SOU EXTENSION 1 FILED
Thursday, November 10, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 2, 2022TEAS EXTENSION RECEIVED
Wednesday, November 2, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, September 6, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 7, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 26, 2022ASSIGNED TO EXAMINER
Tuesday, April 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 18, 2022NEW APPLICATION ENTERED IN TRAM

Related Keywords


axiofill tissue allograft human